SOURCE 2022 has ended
The mission of the Symposium of University Research and Creative Expression (SOURCE) is to provide a university-wide forum for Central Washington University (CWU) students, encouraging equity, diversity, and inclusivity, representing all disciplines and experience levels, to present their mentored research, scholarship, and creative works in a juried environment that meets professional conference standards and expectations.

The 2022 SOURCE program is hybrid. Pre-recorded virtual talks are colored green and can be watched anytime. Live/in-person sessions with Zoom access can be found in the daily schedule. Thank you for joining us!

To vote for the 2023 SOURCE poster, click here
To learn more about SOURCE or give to support the students of Central visit, https://www.cwu.edu/source
Connect on social media with @CentralWashU, @cwusource, #SOURCE2022, #CWUTogether
Back To Schedule
Monday, May 16 • TBA
Evaluation of antileishmanial activity of synthetized thiazolidinone compounds

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Feedback form is now closed.
The leishmaniases are a group of vector-borne parasitic diseases that affect many third world countries including parts of Africa, India, and the Middle East in addition to Southern Europe. It is estimated that worldwide, there are about 3 million new cases of leishmaniases each year leading to as many as 50,000 fatalities annually. There are three clinical forms of the infection: visceral, which is fatal if left untreated and can cause enlargement of spleen and liver; cutaneous, which causes skin lesions and ulcers; and mucocutaneous which destroys the mucus membranes of the nose and/or mouth. The parasite that causes leishmaniasis belongs to the genus Leishmania spp and is transmitted by the female phlebotomine sand fly. The current drugs used to treat leishmaniasis are very toxic with sometime life-threatening side effects. It is therefore urgent to identify new therapeutics with less or no toxicity. In order to contribute to this goal, we will be screening synthetized thiazolidinone compounds for activity against Leishmania spp. A colorimetric assay with Alamar Blue reagent will be utilized to assess the viability of the parasites. We will also screen the compounds for toxicity to mammalian cell using flow cytometry to estimate the proportions of apoptotic and necrotic cells. We hope that at the end of our project to find less toxic and antileishmanial compounds.

avatar for Kiera Bush

Kiera Bush

Undergraduate, Biomedical Science Specialization


Blaise Dondji

Mentor, Biological Sciences

Gabrielle Stryker

Mentor, Biological Sciences

Timothy Beng

Mentor, Chemistry;

Monday May 16, 2022 TBA

Attendees (1)